NCT05557604: Sbrt±sTad for Unfavorable iNtermediate rIsk/High Risk Prostate caNcer
- State
- Under way
- Phase
- Phase 2
- People
- 146 planned
- Started
- 2 Feb 2021
- Primary completion
- 2 Feb 2024
- Arms
- arm 2
- Results
- None posted
- 2 Feb 2021: Trial started
- 28 Sep 2022: Trial registered